Marshall Wace’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-22,500
| Closed | -$417K | – | 2751 |
|
|
2023
Q3 | $417K | Buy |
22,500
+680
| +3% | +$7.69K | ﹤0.01% | 1779 |
|
|
2023
Q2 | $241K | Sell |
21,820
-91,501
| -81% | -$1.27M | ﹤0.01% | 2198 |
|
|
2023
Q1 | $1.52M | Buy |
+113,321
| New | +$1.96M | ﹤0.01% | 1610 |
|
|
2022
Q2 | – | Sell |
-26,836
| Closed | -$436K | – | 3991 |
|
|
2022
Q1 | $436K | Sell |
26,836
-14,192
| -35% | -$222K | ﹤0.01% | 2834 |
|
|
2021
Q4 | $669K | Sell |
41,028
-69,057
| -63% | -$1.16M | ﹤0.01% | 2658 |
|
|
2021
Q3 | $1.64M | Buy |
+110,085
| New | +$1.76M | 0.01% | 1690 |
|
|
2021
Q2 | – | Sell |
-76,723
| Closed | -$1.77M | – | 3250 |
|
|
2021
Q1 | $1.77M | Buy |
76,723
+3,290
| +4% | +$91.7K | 0.01% | 1386 |
|
|
2020
Q4 | $1.81M | Buy |
73,433
+34,805
| +90% | +$1.15M | 0.01% | 985 |
|
|
2020
Q3 | $1.6M | Buy |
+38,628
| New | +$1.77M | 0.01% | 867 |
|
|
2017
Q2 | – | Sell |
-13,463
| Closed | -$1.52M | – | 400 |
|
|
2017
Q1 | $1.52M | Sell |
13,463
-88,897
| -87% | -$10.4M | 0.07% | 176 |
|
|
2016
Q4 | $11.1M | Buy |
102,360
+65,892
| +181% | +$7.85M | 0.07% | 308 |
|
|
2016
Q3 | $6M | Sell |
36,468
-72,659
| -67% | -$11.5M | 0.04% | 374 |
|
|
2016
Q2 | $15.6M | Buy |
109,127
+105,861
| +3,241% | +$15.4M | 0.13% | 178 |
|
|
2016
Q1 | $420K | Buy |
+3,266
| New | +$386K | ﹤0.01% | 878 |
|
|
2015
Q4 | – | Sell |
-7,900
| Closed | -$1.31M | – | 1162 |
|
|
2015
Q3 | $1.31M | Buy |
+7,900
| New | +$1.74M | 0.02% | 572 |
|
|
2014
Q3 | – | Sell |
-1,000
| Closed | -$237K | – | 1082 |
|
|
2014
Q2 | $237K | Buy |
+1,000
| New | +$264K | ﹤0.01% | 811 |
|
Marshall Wace's ICPT Position: Q4 2023 in Review
Marshall Wace sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 22,500 shares — an estimated $417K sold.
Marshall Wace first reported a position in ICPT in Q2 2014 and held it in 16 quarters. The position peaked at $15.6M in Q2 2016. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- Marshall Wace reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Marshall Wace sold 22,500 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $417K.
- Marshall Wace first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2014 and held it in 16 quarters.
- Marshall Wace's Intercept Pharmaceuticals, Inc. position peaked at $15.6M in Q2 2016.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on Marshall Wace's 13F filing for Q4 2023, filed 14 Feb 2024.